Journal article

Polyclonal Heterogeneity: The New Norm for Secondary Clinical Resistance to Targeted Monotherapy in Relapsed Leukemia?

Andrew H Wei, Andrew W Roberts

Cancer Discovery | AMER ASSOC CANCER RESEARCH | Published : 2019

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council of Australia


Funding Acknowledgements

A.W. Roberts is supported by a Practitioner Fellowship from the National Health and Medical Research Council of Australia (1079560).